Laurent Azoulay
-
- Diabetes Treatment and Management 56
- Diabetes Management and Research 14
- Hormonal and reproductive studies 12
- Oncology top 1%
- Cancer Risks and Factors 13
- Cancer Research top 2%
- Internal Medicine top 2%
- Obstetrics and Gynecology top 2%
-
- Metabolism, Diabetes, and Cancer 35
-
- Prostate Cancer Treatment and Research 19
-
- Atrial Fibrillation Management and Outcomes 15
-
- Estrogen and related hormone effects 14
- Co-authors
- Samy SuissaHui YinOriana Hoi Yun YuKristian B. FilionMichaël PollakSophie Dell’AnielloChristel RenouxSerge Benayoun
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Laurent Azoulay
222 papers receiving 7.8k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Endocrinology, Diabetes and Metabolism 2.6k
- Oncology 1.7k
- Cancer Research 821
- Internal Medicine 188
- Obstetrics and Gynecology 351
Countries citing papers authored by Laurent Azoulay
This map shows the geographic impact of Laurent Azoulay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Azoulay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Azoulay more than expected).
Fields of papers citing papers by Laurent Azoulay
This network shows the impact of papers produced by Laurent Azoulay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Azoulay. The network helps show where Laurent Azoulay may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Laurent Azoulay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 1 | |
| 4 | Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort studybreakdown → | 2025 | 16 |
| 5 | 2024 | 4 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 15 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 11 | |
| 13 | 2018 | 21 | |
| 14 | 2017 | 1 | |
| 15 | 2016 | 39 | |
| 16 | 2016 | 27 | |
| 17 | 2014 | 54 | |
| 18 | 2014 | 4 | |
| 19 | Use of Statins and the Risk of Death in Patients With Prostate Cancerbreakdown → | 2013 | 512 |
| 20 | Abstract 18044: Comparison of the CHADS2 and CHA2DS2-VASc Scores in Predicting Stroke Events in Patients With Atrial Fibrillation | 2010 | 3 |
About Laurent Azoulay
Laurent Azoulay is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine and Oncology, having authored 224 papers that have together received 8.0k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (56 papers), Metabolism, Diabetes, and Cancer (35 papers), Prostate Cancer Treatment and Research (19 papers), Atrial Fibrillation Management and Outcomes (15 papers), Estrogen and related hormone effects (14 papers), Diabetes Management and Research (14 papers), Cancer Risks and Factors (13 papers) and Hormonal and reproductive studies (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.6k citations), Oncology (1.7k citations) and Cancer Research (821 citations). Laurent Azoulay has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Samy Suissa, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Michaël Pollak, Sophie Dell’Aniello, Christel Renoux, Serge Benayoun, Haim A. Abenhaim and Armen Aprikian. Their work appears in journals such as New England Journal of Medicine, JAMA and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.